Papers List

Festing, M.F.W., Diamanti, P. and Turton, J.A.   Strain differences in haematological response to chloroamphenicol succinate in mice: implications for toxicological research.    Food and Chemical Toxicology, 39(4), 375-383 (2001).   [Abstract]   [Purchase from publisher]

Festing, M.F.W.   Guidelines for the design and statistical analysis of experiments in papers submitted to ATLA.    ATLA, 29(4), 427-446 (2001).   [Abstract]    [PDF]

Festing, M.F.W.   Experimental approaches to the determination of genetic variability.    Toxicology Letters, 120(1-3), 293-300 (2001).   [Abstract]   [Purchase from publisher]

Gray, S.   More funding must go towards finding alternative non-animal methods.    British Medical Journal, 322(7302), 1603 (2001).   [Abstract]   [Article]

Bhandari, R.N.B., Riccalton, L.A., Lewis, A.L., Fry, J.R., Hammond, A.H., Tendler, S.J.B. and Shakesheff, K.M.    Liver tissue engineering: a role for co-culture systems in modifying hepatocyte function and viability.    Tissue Engineering, 7(3), 345-357 (2001).   [Abstract]   [Purchase from publisher]

Reid, L., Clothier, R.H. and Khammo, N.   Hydrogen peroxide induced stress in human keratinocytes and its effect on bithionol toxicity.    Toxicology in Vitro, 15(4-5), 441-445 (2001)   [Abstract]   [Purchase from publisher]

Gray, A.C. and Clothier, R.H.   The use of an in vitro submerged keratinocyte model to predict induction of squamous metaplasia.    Toxicology in Vitro, 15 (4-5), 427-431(2001).   [Abstract]   [Purchase from publisher]

Gray, S.   Animal tests after the genome - a reply.    The Lancet, 357, 1805 (2001)   [Abstract]   [Available from publisher]

Bremer, S., Worth, A.P., Paparella, M., Bigot, K., Kolossov, E., Fleischmann, B.K., Hescheler, J. and Balls, M.   Establishment of an in vitro reporter gene assay for developmental cardiac toxicity.    Toxicology in Vitro, 15(3), 215-223 (2001).   [Abstract]   [Purchase from publisher]

Anderson, R., Balls, M., Burke, M.D., Cummins, M., Fehily, D., Gray, N., de Groot, M.G., Helin, H., Hunt, C., Jones, D., Price, D., Richert, L., Ravid, R., Shute, D., Sladowski, D., Stone, H., Thasler, W., Trafford, J., van der Valk, J., Weiss, T., Womack, C., and Ylikomi, T.   The establishment of human research tissue banking in the UK and several western European countries the report and recommendations of ECVAM Workshop 44.    ATLA, 29, 125–134 (2001).   [Abstract]    [PDF]

Balls, M.   Attitudes to alternatives to animal experimentation.    ATLA. 29, 631–632 (2001).   [Abstract]    [PDF]

Bottrill, K.   ANDi: “Now, god help thee, poor monkey!”    ATLA, 29, 1–2 (2001).   [Abstract]    [PDF]

Broadhead, C.L. and Combes, R.D.   The current status of food additives toxicity testing and the potential for application of the three Rs.    ATLA, 29, 471–485 (2001).   [Abstract]    [PDF]

Broadhead, C.L. and Watson, J.   Communication of the three Rs within establishments: some problems and solutions report of a LASA alternatives section meeting.    ATLA, 29, 193–197 (2001).   [Abstract]    [PDF]

Bull, S., Langezaal, I., Clothier, R. and Coecke, S.   A genetically engineered cell-based system for detecting metabolism-mediated toxicity.    ATLA. 29, 703–716 (2001).   [Abstract]    [PDF]

Combes, R.D.   Why the US Department of Agriculture should be allowed to insist on inclusion of rodents and birds in the Animal Welfare Act.    ATLA, 29, 85–88 (2001).   [Abstract]    [PDF]

Combes, R.D. and Balls, M.   Ethical investment — what is it, and what are the implications for industry funding of research into alternatives?    ATLA, 29, 55–62 (2001).   [Abstract]    [PDF]

Fry, J. and George, E.   In vitro toxicology in the light of new technologies.    ATLA, 29, 745–748 (2001).   [Abstract]    [PDF]

Jenkins, E.S., Gray, S. and Combes, R.D.   Mutagenesis screens: can they be justified?    ATLA, 29, 63–68 (2001).   [Abstract]    [PDF]

Todd, I., Clothier, R.H., Huggins, M.L., Patel, N., Searle, K.C., Jeyarajah, S., Pradel, L. and Lacey, K.L.   Electrical stimulation of transforming growth factor-β1 secretion by human dermal fibroblasts and the U937 human monocytic cell line.    ATLA, 29, 693–701 (2001).   [Abstract]    [PDF]

Worth, A.P. and Balls, M.   The importance of the prediction model in the validation of alternative tests.    ATLA, 29, 135-143 (2001).   [Abstract]    [PDF]